Biobanks in Horizon 2020: sustainability and attractive perspectives

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11140%2F18%3A10383759" target="_blank" >RIV/00216208:11140/18:10383759 - isvavai.cz</a>

Alternative codes found

RIV/00669806:_____/18:10383759

Result on the web

<a href="https://link.springer.com/content/pdf/10.1007%2Fs13167-018-0153-7.pdf" target="_blank" >https://link.springer.com/content/pdf/10.1007%2Fs13167-018-0153-7.pdf</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1007/s13167-018-0153-7" target="_blank" >10.1007/s13167-018-0153-7</a>

Result language

angličtina

Original language name

Biobanks in Horizon 2020: sustainability and attractive perspectives

Original language description

Biobanks have during last two decades gained an important role in the whole process of biomedical research and health care not only in Europe but also worldwide. Biobanks are one of the pillars in personalised medicine tackling all its aspects such as prevention, diagnosis, treatment and monitoring closely the specific characteristics of an individual patient. The current and future power of biobanks is the amount of samples of high-quality and related information available for current and future research of diseases, for optimising patients &apos; prevention, diagnosis, treatment and monitoring. The material stored in biobanks is a treasure for future technologies that will be able to utilise the currently uncovered information and knowledge. A great and growing number of samples and related information also opens new ways in how to tackle the big data problems and population studies. Biobanks play a substantial role in drug discovery, development and validation. Biobanks are not only an issue of biomedical research, but are becoming a public issue involving patients, to actively participate in biobanking with respect to ethical, legal and social issues. And, finally, biobanking as a multidisciplinary and modern field of science requires appropriate education at all levels of society. To be a world leader in the field of biobanking requires wide international and interdisciplinary collaboration. The topic-dedicated programmes released by the European Commission sustainably support biobank development in Europe and the main tool is the biggest European Union (EU) research and innovation programme ever-Horizon 2020. This article reviews the main Horizon 2020 biobanking projects, financing schemes and the future perspectives.

Czech name

—

Czech description

—

Type

J_imp - Article in a specialist periodical, which is included in the Web of Science database

CEP classification

—

OECD FORD branch

30502 - Other medical science

Project

—

Continuities

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year

2018

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

EPMA Journal [online]

ISSN

1878-5085

e-ISSN

—

Volume of the periodical

9

Issue of the periodical within the volume

4

Country of publishing house

NL - THE KINGDOM OF THE NETHERLANDS

Number of pages

9

Pages from-to

345-353

UT code for WoS article

000451597800001

EID of the result in the Scopus database

2-s2.0-85057453250